cGAS STING Pathway Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

cGAS STING Pathway Market is segmented By Type (Agonist, Antagonist), By Molecule Type (Cyclic Dinucleotides, Non-nucleotides, Live Biotherapeutics, Oncolytic Viruses, Synthetic Peptides), By Therapeutic Area (Oncological Disorders, Inflammatory Disorders, Infectious Diseases, Other Diseases), By Route of Administration (Intratumoral, Intravenous, Subcutaneous, Oral), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa). The report offers the value (in USD Billion) for the above-mentioned segments.

cGAS STING Pathway Market is segmented By Type (Agonist, Antagonist), By Molecule Type (Cyclic Dinucleotides, Non-nucleotides, Live Biotherapeutics, O....

Competitive overview of cGAS STING Pathway Market

The major players operating in the Global cGAS STING Pathway Market include Gilead Sciences, Amgen, Pfizer, Roche, Sanofi, Eli Lilly and Company, Incyte Corporation, Adaptimmune Therapeutics,x CureVac, Immunocore, OncoOne, Sierra Oncology, Celyad Oncology, Zymeworks and TCR2 Therapeutics.